Lipocine Inc.
LPCN
$3.56
$0.257.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.49M | -- | 89.60K | 7.62M | 216.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.49M | -- | 89.60K | 7.62M | 216.20K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 3.49M | -- | 89.60K | 7.62M | 216.20K |
| SG&A Expenses | 873.10K | 1.05M | 1.51M | 1.58M | 1.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.95M | 2.63M | 3.38M | 4.39M | 2.81M |
| Operating Income | 1.55M | -2.63M | -3.29M | 3.22M | -2.59M |
| Income Before Tax | 1.78M | -2.22M | -3.07M | 3.51M | -2.28M |
| Income Tax Expenses | 0.00 | -- | 500.00 | 200.00 | 600.00 |
| Earnings from Continuing Operations | 1.78M | -2.22M | -3.07M | 3.51M | -2.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.78M | -2.22M | -3.07M | 3.51M | -2.28M |
| EBIT | 1.55M | -2.63M | -3.29M | 3.22M | -2.59M |
| EBITDA | 1.56M | -2.62M | -3.28M | 3.23M | -2.59M |
| EPS Basic | 0.33 | -0.41 | -0.57 | 0.66 | -0.43 |
| Normalized Basic EPS | 0.21 | -0.26 | -0.36 | 0.41 | -0.27 |
| EPS Diluted | 0.31 | -0.44 | -0.57 | 0.66 | -0.43 |
| Normalized Diluted EPS | 0.20 | -0.26 | -0.36 | 0.41 | -0.27 |
| Average Basic Shares Outstanding | 5.35M | 5.35M | 5.34M | 5.32M | 5.32M |
| Average Diluted Shares Outstanding | 5.68M | 5.35M | 5.34M | 5.36M | 5.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |